Trial reportNMR in biomedicine2026
Multicenter Assessment of Combined Brain and Cervical Spinal cord 3T MP2RAGE T1 Measurements for Reliable Tissue Microstructure Quantification.
Trial report in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Recent developments in quantitative T1 have enabled simultaneous scanning of both the brain and the cervical spinal cord (cSC) using the magnetization-prepared two rapid acquisition gradient echoes (MP2RAGE) sequence. However, the multicentre variability of such an approach has not yet been assessed. In this paper, we aim to evaluate multicentre variability (inter-scanner, between-session, between-participant) of T1 MP2RAGE measurements in the brain and cSC. A total of 52 MP2RAGE scans were acquired at two centres equipped with Siemens 3T MRI systems using an optimized MP2RAGE sequence. A subset of participants underwent scanning at both centres to evaluate inter-site variability. Between-session and inter-participant variability were assessed both globally and within specific regions, including brain white matter, cortical gray matter, deep gray matter, and cervical spinal cord vertebral levels using a linear mixed effect model. Mean intra-site/inter-site/between-participant coefficients of variation (COV) were 0.4/0.9/2.3% for the brain ROIs and 2.0/2.4/1.7% for the cSC. Our findings validate the consistency and reliability of the MP2RAGE brain and cervical spinal cord simultaneous acquisition in a multicentre setting. This approach has the potential to significantly impact the study of central nervous system pathologies, such as multiple sclerosis, by enabling fast, accurate, and reproducible quantitative imaging collection across multiple centres.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.